The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia
Abstract
Despite intense investigation, mechanisms that facilitate the emergence of the pre-eclampsia phenotype in women are still unknown. Placental hypoxia, hypertension, proteinuria and oedema are the principal clinical features of this disease. It is speculated that hypoxia-driven disruption of the angiogenic balance involving vascular endothelial growth factor (VEGF)/placenta-derived growth factor (PLGF) and soluble Fms-like tyrosine kinase-1 (sFLT-1, the soluble form of VEGF receptor 1) might contribute to some of the maternal symptoms of pre-eclampsia. However, pre-eclampsia does not develop in all women with high sFLT-1 or low PLGF levels, and it also occurs in some women with low sFLT-1 and high PLGF levels. Moreover, recent experiments strongly suggest that several soluble factors affecting the vasculature are probably elevated because of placental hypoxia in the pre-eclamptic women, indicating that upstream molecular defect(s) may contribute to pre-eclampsia. Here we show that pregnant mice deficient in catechol-O-methyltransferase (COMT) show a pre-eclampsia-like phenotype resulting from an absence of 2-methoxyoestradiol (2-ME), a natural metabolite of oestradiol that is elevated during the third trimester of normal human pregnancy. 2-ME ameliorates all pre-eclampsia-like features without toxicity in the Comt(-/-) pregnant mice and suppresses placental hypoxia, hypoxia-inducible factor-1alpha expression and sFLT-1 elevation. The levels of COMT and 2-ME are significantly lower in women with severe pre-eclampsia. Our studies identify a genetic mouse model for pre-eclampsia and suggest that 2-ME may have utility as a plasma and urine diagnostic marker for this disease, and may also serve as a therapeutic supplement to prevent or treat this disorder.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, succinate is also an inhibitor of HIF-1α(213), which has been implicated in the exaggerated production of sFlt-1 and in the pathophysiology of preeclampsia(214, 215)”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [214]
Citations
Cites
Maynard, S. E., Min, J.-Y., Merchan, J., Lim, K.-H., Li, J., Mondal, S., Libermann, T. A., Morgan, J. P., Sellke, F. W., Stillman, I. E., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17189 · Cited by 4,101
Circulating angiogenic factors and the risk of preeclampsia
Levine, R. J., Maynard, S. E., Qian, C., Lim, K.-H., England, L. J., Yu, K. F., Schisterman, E. F., Thadhani, R., Sachs, B. P., Epstein, F. H., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031884 · Cited by 3,720
Circulating angiogenic factors and the risk of preeclampsia*
(2004) · Obstetrics and Gynecology · doi:10.1097/00006250-200405000-00028 · Cited by 2,623
Latest Advances in Understanding Preeclampsia
Redman, C. W., & Sargent, I. L. (2005) · Science · doi:10.1126/science.1111726 · Cited by 2,607
Hypoxia-inducible factor 1: master regulator of O2 homeostasis
Semenza, G. L. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80016-6 · Cited by 1,092
Gogos, J. A., Morgan, M., Luine, V., Santha, M., Ogawa, S., Pfaff, D., & Karayiorgou, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.9991 · Cited by 864
Fotsis, T., Zhang, Y., Pepper, M. S., Adlercreutz, H., Montesano, R., Nawroth, P. P., & Schweigerer, L. (1994) · Nature · doi:10.1038/368237a0 · Cited by 730
2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF
Mabjeesh, N. J., Escuin, D., LaVallee, T. M., Pribluda, V. S., Swartz, G. M., Johnson, M. S., Willard, M. T., Zhong, H., Simons, J. W., & Giannakakou, P. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00077-1 · Cited by 730
Caniggia, I., Mostachfi, H., Winter, J., Gassmann, M., Lye, S. J., Kuliszewski, M., & Post, M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8316 · Cited by 644
Genbačev, O., Joslin, R. J., Damsky, C. H., Polliotti, B., & Fisher, S. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118447 · Cited by 577
Cited by
Sorted by citations
Rana (2019) · doi:10.1161/circresaha.118.313276 · Cited by 2,095
Pre-eclampsia: pathogenesis, novel diagnostics and therapies
Phipps, E. A., Thadhani, R., Benzing, T. R., & Karumanchi, S. A. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0119-6 · Cited by 1,328
Preeclampsia, a Disease of the Maternal Endothelium
Powe, C. E., Levine, R. J., & Karumanchi, S. A. (2011) · Circulation · doi:10.1161/circulationaha.109.853127 · Cited by 987
Pre-eclampsia part 1: current understanding of its pathophysiology
Chaiworapongsa, T., Chaemsaithong, P., Yeo, L., & Romero, R. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.102 · Cited by 956
Challis, J. R., Lockwood, C. J., Myatt, L., Norman, J. E., Strauss, J. F., & Petraglia, F. (2009) · Reproductive Sciences · doi:10.1177/1933719108329095 · Cited by 893
Young, B. C., Levine, R. J., & Karumanchi, S. A. (2010) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102149 · Cited by 734
Why is placentation abnormal in preeclampsia?
Fisher, S. J. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.08.042 · Cited by 643
Preeclampsia: The Role of Angiogenic Factors in Its Pathogenesis
Wang, A., Rana, S., & Karumanchi, S. A. (2009) · Physiology · doi:10.1152/physiol.00043.2008 · Cited by 561
Angiogenic Factors and Preeclampsia
Maynard, S. E., & Karumanchi, S. A. (2011) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2010.10.004 · Cited by 494
Shah, D. A., & Khalil, R. A. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.04.012 · Cited by 422
Ji, L., Brkić, J., Liu, M., Fu, G., Peng, C., & Wang, Y. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.12.008 · Cited by 395
Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model
Kumasawa, K., Ikawa, M., Kidoya, H., Hasuwa, H., Saito‐Fujita, T., Morioka, Y., Takakura, N., Kimura, T., & Okabe, M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011293108 · Cited by 373
Rana, S., Burke, S. D., & Karumanchi, S. A. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.10.022 · Cited by 366
Role of corin in trophoblast invasion and uterine spiral artery remodelling in pregnancy
Cui, Y., Wang, W., Dong, N., Lou, J., Srinivasan, D. K., Cheng, W., Huang, X., Liu, M., Fang, C., Peng, J., et al. (2012) · Nature · doi:10.1038/nature10897 · Cited by 301
The placenta: transcriptional, epigenetic, and physiological integration during development
Maltepe, E., Bakardjiev, A. I., & Fisher, S. J. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41211 · Cited by 316
Preeclampsia: multiple approaches for a multifactorial disease
Pennington, K. A., Schlitt, J. M., Jackson, D. L., Schulz, L. C., & Schust, D. J. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.008516 · Cited by 299
Genetics and the placebo effect: the placebome
Hall, K. T., Loscalzo, J., & Kaptchuk, T. J. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.02.009 · Cited by 281
Beyond oxygen: complex regulation and activity of hypoxia inducible factors in pregnancy
Pringle, K. G., Kind, K. L., Sferruzzi-Perri, A. N., Thompson, J. G., & Roberts, C. T. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmp046 · Cited by 259
Romero, R., Erez, O., Hüttemann, M., Maymon, E., Panaitescu, B., Conde-Agudelo, A., Pacora, P., Yoon, B. H., & Grossman, L. I. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.06.003 · Cited by 253
The role of hypoxia and hypoxia-inducible factor-1alpha in preeclampsia pathogenesis
Tal, R. (2012) · Biology of Reproduction · doi:10.1095/biolreprod.112.102723 · Cited by 235
From pregnancy to preeclampsia: a key role for estrogens
Berkane, N., Liere, P., Oudinet, J.-P., Hertig, A., Lefèvre, G., Pluchino, N., Schumacher, M., & Chabbert-Buffet, N. (2017) · Endocrine Reviews · doi:10.1210/er.2016-1065 · Cited by 223
Brownfoot, F. C., Hastie, R., Hannan, N. J., Cannon, P., Tuohey, L., Parry, L. J., Senadheera, S., Illanes, S. E., Kaitu’u-Lino, T. J., & Tong, S. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.12.019 · Cited by 222
Vascular mechanisms and molecular targets in hypertensive pregnancy and preeclampsia
Qu, H., & Khalil, R. A. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00202.2020 · Cited by 233
Nakashima, A., Tatematsu, M., Fujita, N., Koizumi, K., Shima, T., Yoshida, T., Nikaido, T., Okamoto, A., Yoshimori, T., & Saito, S. (2013) · Autophagy · doi:10.4161/auto.22927 · Cited by 221
Gestational Hypoxia and Developmental Plasticity
Ducsay, C. A., Goyal, R., Pearce, W. J., Wilson, S. M., Hu, X., & Zhang, L. (2018) · Physiological Reviews · doi:10.1152/physrev.00043.2017 · Cited by 208
Maynard, S. E., & Thadhani, R. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008050493 · Cited by 197
Preeclampsia: Novel Mechanisms and Potential Therapeutic Approaches
Armaly, Z., Jadaon, J. E., Jabbour, A. R., & Abassi, Z. A. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00973 · Cited by 217
Groom, K. M., & David, A. L. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.11.565 · Cited by 170
2-Methoxyestradiol—Biology and mechanism of action
Mueck, A. O., & Seeger, H. (2010) · Steroids · doi:10.1016/j.steroids.2010.02.016 · Cited by 171
Progress in solving the sex hormone paradox in pulmonary hypertension
Lahm, T., Tuder, R. M., & Petrache, I. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00337.2013 · Cited by 167
Effects of Hypoxia-Inducible Factor-1α Overexpression in Pregnant Mice
Tal, R., Shaish, A., Barshack, I., Polak‐Charcon, S., Afek, A. B., Volkov, A., Feldman, B., Avivi, C., & Harats, D. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090800 · Cited by 173
Angiogenic Factors in Preeclampsia: From Diagnosis to Therapy
Karumanchi, S. A. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.06421 · Cited by 163
Sex, Gender, and Sex Hormones in Pulmonary Hypertension and Right Ventricular Failure
Hester, J., Ventetuolo, C. E., & Lahm, T. (2019) · Comprehensive physiology · doi:10.1002/cphy.c190011 · Cited by 183
Kanasaki, K., & Kalluri, R. (2009) · Kidney International · doi:10.1038/ki.2009.284 · Cited by 164
Preeclampsia: Pathophysiology and management
Ramadas, N., Divyashree, S., Janhavi, P., Peddha, M. S., & Veeranna, R. P. (2020) · Journal of Gynecology Obstetrics and Human Reproduction · doi:10.1016/j.jogoh.2020.101975 · Cited by 193
Kumar, P., Luo, Y., Tudela, C. M., Alexander, J. M., & Mendelson, C. R. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01228-12 · Cited by 161
Review: Transport across the placenta of mice and women
Dilworth, M. R., & Sibley, C. P. (2013) · Placenta · doi:10.1016/j.placenta.2012.10.011 · Cited by 155
Onda, K., Tong, S., Beard, S., Binder, N. K., Muto, M., Senadheera, S. N., Parry, L. J., Dilworth, M., Renshall, L., Brownfoot, F., et al. (2017) · Hypertension · doi:10.1161/hypertensionaha.116.08408 · Cited by 155
Hypoxia and Placental Development
Soares, M. J., Iqbal, K., & Kozai, K. (2017) · Birth Defects Research · doi:10.1002/bdr2.1135 · Cited by 159
Animal models of preeclampsia; uses and limitations
McCarthy, F. P., Kingdom, J. C., Kenny, L. C., & Walsh, S. K. (2011) · Placenta · doi:10.1016/j.placenta.2011.03.010 · Cited by 154
Kulandavelu, S., Whiteley, K. J., Qu, D., Mu, J., Bainbridge, S. A., & Adamson, S. L. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.187559 · Cited by 147
A New Mouse Model to Explore Therapies for Preeclampsia
Ahmed, A., Singh, J. K., Khan, Y., Seshan, S. V., & Girardi, G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013663 · Cited by 139
Angiogenic Factors in Preeclampsia and Related DisordersPreprint
Cerdeira, A. S., & Karumanchi, S. A. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006585 · Cited by 136
Doridot, L., Passet, B., Méhats, C., Rigourd, V., Barbaux, S., Ducat, A., Mondon, F., Vilotte, M., Castille, J., Breuiller-Fouché, M., et al. (2013) · Hypertension · doi:10.1161/hypertensionaha.111.202994 · Cited by 139
Jobe, S. O., Tyler, C. T., & Magness, R. R. (2013) · Hypertension · doi:10.1161/hypertensionaha.111.201624 · Cited by 118
Gatford, K. L., Andraweera, P. H., Roberts, C. T., & Care, A. S. (2020) · Hypertension · doi:10.1161/hypertensionaha.119.14598 · Cited by 129
Sildenafil Citrate Rescues Fetal Growth in the Catechol- O -Methyl Transferase Knockout Mouse Model
Stanley, J. L., Andersson, I. J., Poudel, R., Rueda‐Clausen, C. F., Sibley, C. P., Davidge, S. T., & Baker, P. N. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.186270 · Cited by 119
Albers, R. E., Kaufman, M. R., Natale, B. V., Keoni, C., Kulkarni-Datar, K. S., Min, S., Williams, C. R., Natale, D. R. C., & Brown, T. L. (2019) · Scientific Reports · doi:10.1038/s41598-019-39426-5 · Cited by 114
Preeklampsja – choroba kobiet w ciąży
Filipek, A., & Jurewicz, E. (2018) · Postępy Biochemii · doi:10.18388/pb.2018_146 · Cited by 111
Steroid profiling in preeclamptic women: evidence for aromatase deficiency
Hertig, A., Lière, P., Chabbert‐Buffet, N., Fort, J., Pianos, A., Eychenne, B., Cambourg, A., Schumacher, M., Berkane, N. B., Lefèvre, G., et al. (2010) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.06.011 · Cited by 110
Molecular genetics of preeclampsia and HELLP syndrome — A review
Jebbink, J. M., Wolters, A., Fernando, F., Afink, G., van der Post, J., & Ris‐Stalpers, C. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.08.004 · Cited by 114
Secretory products of the corpus luteum and preeclampsia
Pereira, M. M., Mainigi, M. A., & Strauss, J. F. (2021) · Human Reproduction Update · doi:10.1093/humupd/dmab003 · Cited by 107
New Developments in the Pathogenesis of Preeclampsia
Naljayan, M. V., & Karumanchi, S. A. (2013) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2013.02.003 · Cited by 97
Reslan, O. M., & Khalil, R. A. (2010) · Cardiovascular & Hematological Agents in Medicinal Chemistry · doi:10.2174/187152510792481234 · Cited by 95
Lee, S. B., Wong, A. P., Kanasaki, K., Xu, Y., Shenoy, V. K., McElrath, T. F., Whitesides, G. M., & Kalluri, R. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090513 · Cited by 93
Soares, M. J., Chakraborty, D., Kubota, K., Renaud, S. J., & Rumi, M. A. K. (2014) · The International Journal of Developmental Biology · doi:10.1387/ijdb.140083ms · Cited by 91
Ali, S. M. J., & Khalil, R. A. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2015.1067684 · Cited by 92
Nitric oxide signaling in pregnancy and preeclampsia
Sutton, E. F., Gemmel, M., & Powers, R. W. (2019) · Nitric Oxide · doi:10.1016/j.niox.2019.11.006 · Cited by 96
Rolfo, A., Giuffrida, D., Nuzzo, A. M., Pierobon, D., Cardaropoli, S., Piccoli, E., Giovarelli, M., & Todros, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059403 · Cited by 87
Zhang, M., Muralimanoharan, S., Wortman, A. C., & Mendelson, C. R. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1607849113 · Cited by 87
Kalkunte, S. S., Boij, R., Norris, W. E., Friedman, J. F., Lai, Z., Kurtis, J. D., Lim, K.-H., Padbury, J. F., Matthiesen, L., & Sharma, S. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100475 · Cited by 86
Therapeutic Promises of 2-Methoxyestradiol and Its Drug Disposition Challenges
Verenich, S., & Gerk, P. M. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100190f · Cited by 83
Pre-eclampsia: connecting angiogenic and metabolic pathways
Shenoy, V. K., Kanasaki, K., & Kalluri, R. (2010) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2010.05.002 · Cited by 83
Targeted inhibition of complement activation prevents features of preeclampsia in mice
Qing, X., Redecha, P. B., Burmeister, M. A., Tomlinson, S., D’Agati, V. D., Davisson, R. L., & Salmon, J. E. (2010) · Kidney International · doi:10.1038/ki.2010.393 · Cited by 86
Preeclampsia, Hypoxia, Thrombosis, and Inflammation
Shamshirsaz, A. A., Paidas, M. J., & Krikun, G. (2011) · Journal of Pregnancy · doi:10.1155/2012/374047 · Cited by 83
Trophoblast-Specific Conditional Atg7 Knockout Mice Develop Gestational Hypertension
Aoki, A., Nakashima, A., Kusabiraki, T., Ono, Y., Yoshino, O., Muto, M., Kumasawa, K., Yoshimori, T., Ikawa, M., & Saito, S. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.07.021 · Cited by 81
Estrogen Receptors and Estrogen-Induced Uterine Vasodilation in Pregnancy
Bai, J., Qi, Q.-R., Li, Y., Day, R., Makhoul, J., Magness, R. R., & Chen, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124349 · Cited by 82
Translational value of animal models of kidney failure
Ortíz, A., Sánchez-Niño, M. D., Izquierdo, M. C., Martín-Cleary, C., García‐Bermejo, L., Moreno, J. A., Ruiz‐Ortega, M., Draibe, J. B., Cruzado, J. M., García-González, M. Á., et al. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.026 · Cited by 79
Mechanism of Hypoxia-induced GCM1 Degradation
Chiang, M.-H., Liang, F.-Y., Chen, C., Chang, C., Cheong, M.-L. J., Wang, L., Liang, C.-Y., Lin, F., Chou, C.-C., & Chen, H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.016170 · Cited by 78
Effects of Resveratrol in Pregnancy Using Murine Models with Reduced Blood Supply to the Uterus
Poudel, R., Stanley, J. L., Rueda‐Clausen, C. F., Andersson, I. J., Sibley, C. P., Davidge, S. T., & Baker, P. N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064401 · Cited by 78
Thomas, C. P., Andrews, J. I., Raikwar, N. S., Kelley, E. A., Herse, F., Dechend, R., Golos, T. G., & Liu, K. Z. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0017 · Cited by 82
Maternal Vascular Physiology in Preeclampsia
Goulopoulou, S. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.08821 · Cited by 78
The reduction in circulating levels of estrogen and progesterone in women with preeclampsia
Wan, J., Hu, Z., Zeng, K., Yin, Y., Zhao, M., Chen, M., & Chen, Q. (2017) · Pregnancy Hypertension · doi:10.1016/j.preghy.2017.12.003 · Cited by 81
Liu, N. Q., Ouyang, Y. Q., Bulut, Y., Lagishetty, V., Chan, S., Hollis, B. W., Wagner, C. L., Equils, O., & Hewison, M. (2013) · Endocrinology · doi:10.1210/en.2012-2270 · Cited by 77
Jim, B., Sharma, S., Kebede, T., & Acharya, A. (2010) · Cardiology in Review · doi:10.1097/crd.0b013e3181c60ca6 · Cited by 74
Jobe, S. O., Ramadoss, J., Koch, J. M., Jiang, Y., Zheng, J. J., & Magness, R. R. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.146399 · Cited by 73
Cancer Biology and Prevention in Diabetes
Srivastava, S. P., & Goodwin, J. E. (2020) · Cells · doi:10.3390/cells9061380 · Cited by 77
Placental Aromatase Is Deficient in Placental Ischemia and Preeclampsia
Pérez‐Sepúlveda, A., Monteiro, L. J., Dobierzewska, A., España-Perrot, P. P., Venegas, P., Guzmán-Rojas, A. M., Agurto, M. I. G., Palominos-Rivera, M., Irarrázabal, C. E., Horacio Figueroa, D., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139682 · Cited by 72
Sheikh, A., Small, H. Y., Currie, G. E., & Delles, C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160808 · Cited by 73
Angiogenic factors and preeclampsia
Steinberg, G., Khankin, E. V., & Karumanchi, S. A. (2009) · Thrombosis Research · doi:10.1016/s0049-3848(09)70020-9 · Cited by 75
Oestradiol metabolism and androgen receptor genotypes are associated with right ventricular function
Ventetuolo, C. E., Mitra, N., Wan, F., Manichaikul, A. W., Barr, R. G., Johnson, C. W., Bluemke, D. A., Lima, J. A. C., Tandri, H., Ouyang, P., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01083-2015 · Cited by 69
Etiopathogenesis, prediction, and prevention of preeclampsia
Correa, P. J., Palmeiro-Silva, Y. K., Soto, M. J., Ugarte, C. M. D., & Illanes, S. E. (2016) · Hypertension in Pregnancy · doi:10.1080/10641955.2016.1181180 · Cited by 69
Pregnancy, preeclampsia and maternal aging: From epidemiology to functional genomics
Miller, E. C., Wilczek, A., Bello, N. A., Tom, S. E., Wapner, R. J., & Suh, Y. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101535 · Cited by 78
Sex, hormones and neuroeffector mechanisms
Hart, E. C., Charkoudian, N., & Miller, V. M. (2010) · Acta Physiologica · doi:10.1111/j.1748-1716.2010.02192.x · Cited by 68
Animal models of preeclampsia: translational failings and why
Marshall, S. A., Hannan, N. J., Jelinic, M., Nguyen, T., Girling, J. E., & Parry, L. J. (2017) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00355.2017 · Cited by 65
Treating the dysfunctional placenta
Sibley, C. P. (2017) · Journal of Endocrinology · doi:10.1530/joe-17-0185 · Cited by 66
Crosley, E. J., Elliot, M. G., Christians, J. K., & Crespi, B. J. (2013) · Placenta · doi:10.1016/j.placenta.2012.12.001 · Cited by 62
Bastos, P., Gomes, T. M. B., & Ribeiro, L. V. P. T. (2017) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2017_2 · Cited by 62
Potential vascular actions of 2-methoxyestradiol
Dubey, R. K., & Jackson, E. K. (2009) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2009.04.007 · Cited by 62
Epistasis between COMT and MTHFR in Maternal-Fetal Dyads Increases Risk for Preeclampsia
Hill, L. D., York, T. P., Kusanovic, J. P., Gómez, R., Eaves, L. J., Romero, R. J., & Strauss, J. F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016681 · Cited by 63
Plasma-Mediated Vascular Dysfunction in the Reduced Uterine Perfusion Pressure Model of Preeclampsia
Walsh, S. K., English, F. A., Johns, E. J., & Kenny, L. C. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.132191 · Cited by 60
Dietary melatonin alters uterine artery hemodynamics in pregnant Holstein heifers
Brockus, K., Hart, C. G., Gilfeather, C. L., Fleming, B. O., & Lemley, C. O. (2015) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2015.10.006 · Cited by 62
Zhu, M., Ren, Z., Possomato‐Vieira, J. S., & Khalil, R. A. (2016) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00137.2016 · Cited by 62
Shu, W., Li, H., Gong, H., Zhang, M., Niu, X., Ma, Y., Zhang, X., Cai, W., Yang, G.-H., Wei, M., et al. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6217 · Cited by 65
Hertig, A., & Lière, P. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.07.020 · Cited by 56
Diabetic angiopathy and angiogenic defects
Xu, L., Kanasaki, K., Kitada, M., & Koya, D. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-13 · Cited by 58
Placental ischemia and cardiovascular dysfunction in preeclampsia and beyond: making the connections
Gilbert, J. S., Nijland, M. J., & Knoblich, P. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.10.1367 · Cited by 56
Abnormal steroidogenesis and aromatase activity in preeclampsia
Berkane, N. B., Lière, P., Lefèvre, G., Alfaidy, N., Nahed, R. A., Vincent, J., Oudinet, J., Pianos, A., Cambourg, A., Rozenberg, P., et al. (2018) · Placenta · doi:10.1016/j.placenta.2018.07.004 · Cited by 56
Roten, L. T., Fenstad, M. H., Forsmo, S., Johnson, M. P., Moses, E. K., Austgulen, R., & Skorpen, F. (2011) · Molecular Human Reproduction · doi:10.1093/molehr/gar014 · Cited by 56
Loss of placental growth factor ameliorates maternal hypertension and preeclampsia in mice
Parchem, J. G., Kanasaki, K., Kanasaki, M., Sugimoto, H., Xie, L., Hamano, Y., Lee, S. B., Gattone, V. H., Parry, S. I., Strauss, J. F., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99026 · Cited by 54
Metadata
- Authors
- Kanasaki, K., Palmsten, K., Sugimoto, H., Ahmad, S., Hamano, Y., Xie, L., Parry, S., Augustin, H. G., Gattone, V. H., Folkman, J., Strauss, J. F., & Kalluri, R.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Birmingham Women's Hospital (GB)
- University of Pennsylvania (US)
- German Cancer Research Center (DE)
- Indiana University Indianapolis (US)
- Boston Children's Hospital (US)
- Virginia Commonwealth University (US)
- Corresponding author
- Kalluri, Raghu
- ORCID
- Venue
- Nature
- Published
- 2008-05-11
- Volume
- 453
- Issue
- 7198
- Pages
- 1117-1121
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2066278927
- Cited by
- 381
- References
- 34
- Citations by year
- 2026: 4 · 2025: 12 · 2024: 8 · 2023: 8 · 2022: 13 · 2021: 18 · 2020: 22 · 2019: 27 · 2018: 28 · 2017: 31 · 2016: 16 · 2015: 22 · 2014: 29 · 2013: 22 · 2012: 29
- FWCI
- 34.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Funders
- Beth Israel Deaconess Medical Center
- University of Pennsylvania
- British Heart Foundation
- Fondation pour la Recherche Médicale
- Georg-August-Universität Göttingen
- Kanae Foundation for the Promotion of Medical Science
- National Institutes of Health
- Medical Research Council
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 62987, DK61688, R01DK062987, DK 13193, DK-55001, R01DK061688, R01DK055001)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Health Sciences › Medicine › Clinical Neurology › Neurological Complications and Syndromes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- preeclampsia, catechol-O-methyltransferase, 2-methoxyestradiol, placental hypoxia, angiogenic imbalance, soluble fms-like tyrosine kinase-1, vascular endothelial growth factor, placental growth factor, placenta, pregnancy complications, therapeutic target, proteinuria, hypertension, edema
- MeSH terms
- 2-Methoxyestradiol, Albumins, Animals, Hypoxia, Blood Pressure, Catechol O-Methyltransferase, Creatinine, Disease Models, Animal, Estradiol, Female, Humans, Hypertension, Killer Cells, Natural, Litter Size, Male, Placenta, Pre-Eclampsia, Pregnancy, Proteinuria, Vascular Endothelial Growth Factor Receptor-1, Mice, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review